Financial Comparison

Cipla Limited vs Divi's Laboratories Limited

Click a ticker to view the full analysis.

CIPLA.NS vs

In short

Divi's Laboratories Limited is the more profitable of the two, keeping 24.5% of revenue as net profit against 14.0% for Cipla Limited. Divi's Laboratories Limited trades at the higher trailing P/E (91.9× vs 39.0× for Cipla Limited), so investors pay more for each dollar of its earnings. Fisclear flags 0 medium- or high-severity risks for Cipla Limited and 1 for Divi's Laboratories Limited.

Based on filings for periods ending 31 Mar 2026 (CIPLA.NS) and 31 Mar 2026 (DIVISLAB.NS) · Updated

FisclearScore Comparison

CIPLA.NS51Fair
DIVISLAB.NS55Fair
Quality+6
89
83
Efficiency+15
47
62
Value
26
26
Cashflow+14
25
39
Regime
55
55
Peers
58
58

FisclearScore is a quantitative model. CIPLA.NS shown solid · DIVISLAB.NS shown dashed. Not financial advice.

MetricCIPLA.NSDIVISLAB.NS
Price₹1,397.10₹10,097.00
Market Cap₹1.13T₹2.68T
P/E (TTM)39.0x91.9x
P/B3.2x16.0x
Beta0.100.18
Div Yield0.93%0.30%
Revenue (TTM)₹277.1B₹104.8B
Net Income₹38.8B₹25.7B
Gross Margin62.3%59.1%
Risk Flags—2 flags

Related comparisons

Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.